HCA · HCA Healthcare, Inc. · Debt

On April 30, 2026, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent Guarantor”), completed the public offering of (i) $1,000,000,000 aggregate principal amount of its 4.700% Senior Notes due 2031 (the “2031 Notes”), (ii) $750,000,000 aggregate principal amount of its 5.000% Senior Notes due 2033 (the “2033 Notes”) and (iii) $1,250,000,000 aggregate principal amount of its 5.300% Senior Notes due 2036 (the “2036 Notes” and, together with the 2031 Notes and the 2033 Notes, the “Notes”), each guaranteed on a senior unsecured basis by the Parent Guarantor. The Notes have been registered under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to the Issuer’s and the Parent Guarantor’s shelf registration statement on Form S-3, filed on April 27, 2026 (File No. 333-295336) (the “Registration Statement”), as supplemented by the prospectus supplement dated April 27, 2026, previously filed with the Securities and Exchange Commission under the Securities Act.

Issuer evidence: On April 30, 2026, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent Guarantor”), completed the public offering of (i) $1,000,000,000 aggregate principal amount of its 4.700% Senior Notes due 2031 (the “2031 Notes”), (ii) $750,000,000 aggregate principal amount of its 5.000% Senior Notes due 2033 (the “2033 Notes”) and (iii) $1,250,000,000 aggregate principal amount of its 5.300% Senior Notes due 2036 (the “2036 Notes” and, together with the 2031 Notes and the 2033 Notes, the “Notes”), each guaranteed on a senior unsecured basis by the Parent Guarantor. The Notes have been registered under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to the Issuer’s and the Parent Guarantor’s shelf registration statement on Form S-3, filed on April 27, 2026 (File No. 333-295336) (the “Registration Statement”), as supplemented by the prospectus supplement dated April 27, 2026, previously filed with the Securities and Exchange Commission under the Securities Act.

Supporting evidence: The 2031 Notes will mature on May 15, 2031, the 2033 Notes will mature on May 15, 2033 and the 2036 Notes will mature on May 15, 2036. Interest on the 2031 Notes, the 2033 Notes and the 2036 Notes will be payable semi-annually, on May 15 and November 15 of each year, commencing on November 15, 2026, to holders of record on the preceding May 1 or November 1, as the case may be, provided that for so long as the Notes of a series are held by The Depository Trust Company, the record date for the Notes of such series will be the close of business on the business day preceding the applicable interest payment date.

Supporting evidence: On April 30, 2026, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent Guarantor”), completed the public offering of (i) $1,000,000,000 aggregate principal amount of its 4.700% Senior Notes due 2031 (the “2031 Notes”), (ii) $750,000,000 aggregate principal amount of its 5.000% Senior Notes due 2033 (the “2033 Notes”) and (iii) $1,250,000,000 aggregate principal amount of its 5.300% Senior Notes due 2036 (the “2036 Notes” and, together with the 2031 Notes and the 2033 Notes, the “Notes”), each guaranteed on a senior unsecured basis by the Parent Guarantor. The Notes have been registered under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to the Issuer’s and the Parent Guarantor’s shelf registration statement on Form S-3, filed on April 27, 2026 (File No. 333-295336) (the “Registration Statement”), as supplemented by the prospectus supplement dated April 27, 2026, previously filed with the Securities and Exchange Commission under the Securities Act.

Supporting evidence: On April 30, 2026, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent Guarantor”), completed the public offering of (i) $1,000,000,000 aggregate principal amount of its 4.700% Senior Notes due 2031 (the “2031 Notes”), (ii) $750,000,000 aggregate principal amount of its 5.000% Senior Notes due 2033 (the “2033 Notes”) and (iii) $1,250,000,000 aggregate principal amount of its 5.300% Senior Notes due 2036 (the “2036 Notes” and, together with the 2031 Notes and the 2033 Notes, the “Notes”), each guaranteed on a senior unsecured basis by the Parent Guarantor. The Notes have been registered under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to the Issuer’s and the Parent Guarantor’s shelf registration statement on Form S-3, filed on April 27, 2026 (File No. 333-295336) (the “Registration Statement”), as supplemented by the prospectus supplement dated April 27, 2026, previously filed with the Securities and Exchange Commission under the Securities Act.

On April 30, 2026, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent Guarantor”), completed the public offering of (i) $1,000,000,000 aggregate principal amount of its 4.700% Senior Notes due 2031 (the “2031 Notes”), (ii) $750,000,000 aggregate principal amount of its 5.000% Senior Notes due 2033 (the “2033 Notes”) and (iii) $1,250,000,000 aggregate principal amount of its 5.300% Senior Notes due 2036 (the “2036 Notes” and, together with the 2031 Notes and the 2033 Notes, the “Notes”), each guaranteed on a senior unsecured basis by the Parent Guarantor. The Notes have been registered under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to the Issuer’s and the Parent Guarantor’s shelf registration statement on Form S-3, filed on April 27, 2026 (File No. 333-295336) (the “Registration Statement”), as supplemented by the prospectus supplement dated April 27, 2026, previously filed with the Securities and Exchange Commission under the Securities Act.

Issuer evidence: On April 30, 2026, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent Guarantor”), completed the public offering of (i) $1,000,000,000 aggregate principal amount of its 4.700% Senior Notes due 2031 (the “2031 Notes”), (ii) $750,000,000 aggregate principal amount of its 5.000% Senior Notes due 2033 (the “2033 Notes”) and (iii) $1,250,000,000 aggregate principal amount of its 5.300% Senior Notes due 2036 (the “2036 Notes” and, together with the 2031 Notes and the 2033 Notes, the “Notes”), each guaranteed on a senior unsecured basis by the Parent Guarantor. The Notes have been registered under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to the Issuer’s and the Parent Guarantor’s shelf registration statement on Form S-3, filed on April 27, 2026 (File No. 333-295336) (the “Registration Statement”), as supplemented by the prospectus supplement dated April 27, 2026, previously filed with the Securities and Exchange Commission under the Securities Act.

Supporting evidence: The 2031 Notes will mature on May 15, 2031, the 2033 Notes will mature on May 15, 2033 and the 2036 Notes will mature on May 15, 2036. Interest on the 2031 Notes, the 2033 Notes and the 2036 Notes will be payable semi-annually, on May 15 and November 15 of each year, commencing on November 15, 2026, to holders of record on the preceding May 1 or November 1, as the case may be, provided that for so long as the Notes of a series are held by The Depository Trust Company, the record date for the Notes of such series will be the close of business on the business day preceding the applicable interest payment date.

Supporting evidence: On April 30, 2026, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent Guarantor”), completed the public offering of (i) $1,000,000,000 aggregate principal amount of its 4.700% Senior Notes due 2031 (the “2031 Notes”), (ii) $750,000,000 aggregate principal amount of its 5.000% Senior Notes due 2033 (the “2033 Notes”) and (iii) $1,250,000,000 aggregate principal amount of its 5.300% Senior Notes due 2036 (the “2036 Notes” and, together with the 2031 Notes and the 2033 Notes, the “Notes”), each guaranteed on a senior unsecured basis by the Parent Guarantor. The Notes have been registered under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to the Issuer’s and the Parent Guarantor’s shelf registration statement on Form S-3, filed on April 27, 2026 (File No. 333-295336) (the “Registration Statement”), as supplemented by the prospectus supplement dated April 27, 2026, previously filed with the Securities and Exchange Commission under the Securities Act.

Supporting evidence: On April 30, 2026, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent Guarantor”), completed the public offering of (i) $1,000,000,000 aggregate principal amount of its 4.700% Senior Notes due 2031 (the “2031 Notes”), (ii) $750,000,000 aggregate principal amount of its 5.000% Senior Notes due 2033 (the “2033 Notes”) and (iii) $1,250,000,000 aggregate principal amount of its 5.300% Senior Notes due 2036 (the “2036 Notes” and, together with the 2031 Notes and the 2033 Notes, the “Notes”), each guaranteed on a senior unsecured basis by the Parent Guarantor. The Notes have been registered under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to the Issuer’s and the Parent Guarantor’s shelf registration statement on Form S-3, filed on April 27, 2026 (File No. 333-295336) (the “Registration Statement”), as supplemented by the prospectus supplement dated April 27, 2026, previously filed with the Securities and Exchange Commission under the Securities Act.

On April 30, 2026, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent Guarantor”), completed the public offering of (i) $1,000,000,000 aggregate principal amount of its 4.700% Senior Notes due 2031 (the “2031 Notes”), (ii) $750,000,000 aggregate principal amount of its 5.000% Senior Notes due 2033 (the “2033 Notes”) and (iii) $1,250,000,000 aggregate principal amount of its 5.300% Senior Notes due 2036 (the “2036 Notes” and, together with the 2031 Notes and the 2033 Notes, the “Notes”), each guaranteed on a senior unsecured basis by the Parent Guarantor. The Notes have been registered under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to the Issuer’s and the Parent Guarantor’s shelf registration statement on Form S-3, filed on April 27, 2026 (File No. 333-295336) (the “Registration Statement”), as supplemented by the prospectus supplement dated April 27, 2026, previously filed with the Securities and Exchange Commission under the Securities Act.

Issuer evidence: On April 30, 2026, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent Guarantor”), completed the public offering of (i) $1,000,000,000 aggregate principal amount of its 4.700% Senior Notes due 2031 (the “2031 Notes”), (ii) $750,000,000 aggregate principal amount of its 5.000% Senior Notes due 2033 (the “2033 Notes”) and (iii) $1,250,000,000 aggregate principal amount of its 5.300% Senior Notes due 2036 (the “2036 Notes” and, together with the 2031 Notes and the 2033 Notes, the “Notes”), each guaranteed on a senior unsecured basis by the Parent Guarantor. The Notes have been registered under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to the Issuer’s and the Parent Guarantor’s shelf registration statement on Form S-3, filed on April 27, 2026 (File No. 333-295336) (the “Registration Statement”), as supplemented by the prospectus supplement dated April 27, 2026, previously filed with the Securities and Exchange Commission under the Securities Act.

Supporting evidence: The 2031 Notes will mature on May 15, 2031, the 2033 Notes will mature on May 15, 2033 and the 2036 Notes will mature on May 15, 2036. Interest on the 2031 Notes, the 2033 Notes and the 2036 Notes will be payable semi-annually, on May 15 and November 15 of each year, commencing on November 15, 2026, to holders of record on the preceding May 1 or November 1, as the case may be, provided that for so long as the Notes of a series are held by The Depository Trust Company, the record date for the Notes of such series will be the close of business on the business day preceding the applicable interest payment date.

Supporting evidence: On April 30, 2026, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent Guarantor”), completed the public offering of (i) $1,000,000,000 aggregate principal amount of its 4.700% Senior Notes due 2031 (the “2031 Notes”), (ii) $750,000,000 aggregate principal amount of its 5.000% Senior Notes due 2033 (the “2033 Notes”) and (iii) $1,250,000,000 aggregate principal amount of its 5.300% Senior Notes due 2036 (the “2036 Notes” and, together with the 2031 Notes and the 2033 Notes, the “Notes”), each guaranteed on a senior unsecured basis by the Parent Guarantor. The Notes have been registered under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to the Issuer’s and the Parent Guarantor’s shelf registration statement on Form S-3, filed on April 27, 2026 (File No. 333-295336) (the “Registration Statement”), as supplemented by the prospectus supplement dated April 27, 2026, previously filed with the Securities and Exchange Commission under the Securities Act.

Supporting evidence: On April 30, 2026, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent Guarantor”), completed the public offering of (i) $1,000,000,000 aggregate principal amount of its 4.700% Senior Notes due 2031 (the “2031 Notes”), (ii) $750,000,000 aggregate principal amount of its 5.000% Senior Notes due 2033 (the “2033 Notes”) and (iii) $1,250,000,000 aggregate principal amount of its 5.300% Senior Notes due 2036 (the “2036 Notes” and, together with the 2031 Notes and the 2033 Notes, the “Notes”), each guaranteed on a senior unsecured basis by the Parent Guarantor. The Notes have been registered under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to the Issuer’s and the Parent Guarantor’s shelf registration statement on Form S-3, filed on April 27, 2026 (File No. 333-295336) (the “Registration Statement”), as supplemented by the prospectus supplement dated April 27, 2026, previously filed with the Securities and Exchange Commission under the Securities Act.